USA - Alpha Briefing

Alpha Briefing

Sign in Subscribe

USA

A collection of 9 posts

🌍 The 96-Hour Window: If the U.S. and Israel Hit Iran, What Breaks First — and What Trades First

Paid-members only

🌍 The 96-Hour Window: If the U.S. and Israel Hit Iran, What Breaks First — and What Trades First

If the U.S. and Israel strike Iran, markets won’t wait for headlines. Oil, defense, cyber, and shipping could move within hours. We break down the 96-hour war scenario, regime-change odds, and the stocks positioned to react first.

🎲 Washington Gridlock, Middle East Gamble

Paid-members only

🎲 Washington Gridlock, Middle East Gamble

Day 5 of the shutdown collides with fragile Gaza peace talks. Washington gridlock weakens U.S. credibility abroad as markets brace for binary outcomes: troop paychecks at risk at home, truce or escalation overseas. The stakes for investors have never been sharper.

🇺🇸 This Week at the White House: From War Rooms to Trade Rooms, Power Was on Display

🇺🇸 This Week at the White House: From War Rooms to Trade Rooms, Power Was on Display

⚔️ What to Watch If the U.S. Enters the Israel–Iran War

Energy & Strategic Trends Featured

⚔️ What to Watch If the U.S. Enters the Israel–Iran War

🧠 AlphaBriefing Premium Exclusive: Top 10 Stocks Under $5 to Buy Now

Paid-members only

Premium Briefing Featured

🧠 AlphaBriefing Premium Exclusive: Top 10 Stocks Under $5 to Buy Now

🛰️ ALPHA BRIEFING | INTEL BULLETIN: Meme Warfare Escalates: Tesla Down, Trump Mad, China on Line 1

🛰️ ALPHA BRIEFING | INTEL BULLETIN: Meme Warfare Escalates: Tesla Down, Trump Mad, China on Line 1

🔍 AlphaBriefing Premium Intel – June 1, 2025

Paid-members only

Energy & Strategic Trends Featured

🔍 AlphaBriefing Premium Intel – June 1, 2025

🧠 PSYOP for Profit: Can Behavioral Finance Predict Wartime Markets?

🧠 PSYOP for Profit: Can Behavioral Finance Predict Wartime Markets?

Can psychological operations (PSYOP) principles help us predict market behavior during conflict? Spoiler: They already are.

🧬 OTLK: Outlook Therapeutics Poised for a Defining FDA Decision in 2025

Paid-members only

Biotech Featured

🧬 OTLK: Outlook Therapeutics Poised for a Defining FDA Decision in 2025

Operated by veterans. Driven by discipline. Built for the early mover.
AlphaBriefing provides financial commentary and market analysis for informational purposes only. We do not offer personalized investment advice. All content is opinion-based and should not be considered a recommendation to buy or sell any security. Past performance is not indicative of future results. Investing involves risk, including the potential loss of principal. Individual results may vary. We value your privacy. Any data collected is used to improve your experience and to provide relevant updates about our services.
©2025 AlphaBriefing. All rights reserved. | Privacy Policy | Legal Disclaimer